SCHEMBL27008239

SCHEMBL27008239

NC(=O)C1=Nc2ccccc2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.50
NOS1 P29475 2/20 0.50
NOS2 P35228 2/20 0.50
TRPA1 O75762 6/20 0.45
SIGMAR1 Q99720 1/20 0.40
RECQL P46063 2/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
PARP1 P09874 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
CYP2D6 P10635 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28406756 0.83 NOS3 (0.63) NOS3NOS1NOS2TRPA1SIGMAR1
SCHEMBL515808 0.82 TRPA1 (0.44) NOS3NOS1NOS2TRPA1SIGMAR1
SCHEMBL29697828 0.82 TRPA1 (0.44) NOS3NOS1NOS2TRPA1SIGMAR1
SCHEMBL13356491 0.81 NOS3 (0.41) NOS3NOS1NOS2TRPA1SIGMAR1
SCHEMBL10176168 0.78 ALDH1A1 (0.45) NOS3NOS1NOS2TRPA1SIGMAR1
SCHEMBL84394 0.77 NOS3 (0.65) NOS3NOS1NOS2TRPA1SIGMAR1
SCHEMBL19690478 0.77 TRPA1 (0.51) NOS3NOS1NOS2TRPA1POLB
SCHEMBL11989043 0.77 HRH1 (0.38) NOS3NOS1NOS2TRPA1SIGMAR1
SCHEMBL31544358 0.77 SIRT3 (0.43) TRPA1SIGMAR1MAPTTSHRTDP1
SCHEMBL9060888 0.77 ALDH1A1 (0.40) NOS3NOS1NOS2TRPA1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018119-A1 CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS TRINEURO (KR) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018119-A1 CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS MAOA, DRD2, MAOB NOS3 1606/4885NOS1 1259/4885NOS2 1299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.